Zimmer Biomet Holdings Inc/ US98956P1021 /
| 15.11.2024 21:59:59 | Diff. +3,63 | Volumen | Geld- | Brief- | Marktkapitalisierung | Dividendenr. | KGV |
|---|---|---|---|---|---|---|---|
| 112,50USD | +3,33% | 139.726 Umsatz: 15,62 Mio. |
-Geld Vol: - | -Brief Vol: - | 22,4 Mrd.USD | 0,85% | 22,92 |
Aktiva
| 2016 US GAAP in Mio. USD |
2017 US GAAP in Mio. USD |
2018 US GAAP in Mio. USD |
2019 US GAAP in Mio. USD |
2020 US GAAP in Mio. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sachanlagen | 2.037,9000 | 2.038,6000 | 2.015,4000 | 2.077,4000 | 2.047,7000 | ||||||
| Immaterielle Vermögensgegenstände | 8.785,4000 | 8.353,4000 | 7.684,6000 | 7.257,6000 | 7.055,5000 | ||||||
| Finanzanlagen | - | - | - | - | - | ||||||
| Anlagevermögen | 22.020,8000 | 21.449,2000 | 19.699,4000 | 19.914,8000 | 19.334,4000 | ||||||
| Vorräte | 1.959,4000 | 2.081,8000 | 2.256,5000 | 2.385 | 2.450,7000 | ||||||
| Forderungen | 1.604,4000 | 1.494,6000 | 1.275,8000 | 1.363,9000 | 1.452,7000 | ||||||
| Liquide Mitteln | 634,1000 | 524,4000 | 542,8000 | 617,9000 | 802,1000 | ||||||
| Umlaufvermögen | 4.663,6000 | 4.515,3000 | 4.427,4000 | 4.723,9000 | 5.083,3000 | ||||||
| Aktiva, gesamt | 26.684,4000 | 25.964,5000 | 24.126,8000 | 24.638,7000 | 24.417,7000 | ||||||
Passiva
| 2016 US GAAP in Mio. USD |
2017 US GAAP in Mio. USD |
2018 US GAAP in Mio. USD |
2019 US GAAP in Mio. USD |
2020 US GAAP in Mio. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Verbindlichkeiten aus Lieferungen und Leistungen | 364,5000 | 330,2000 | 362,6000 | 400,9000 | 330 | ||||||
| Langfristige Schulden | 10.665,8000 | 8.917,5000 | 8.413,7000 | 6.721,4000 | 7.626,5000 | ||||||
| Verbindlichkeiten gegenüber Kreditinstituten | - | - | - | - | - | ||||||
| Rückstellungen | 3.030,9000 | 1.101,5000 | 999,5000 | 840,1000 | 790,4000 | ||||||
| Verbindlichkeiten | 17.014,5000 | 14.229 | 12.850,7000 | 12.245,9000 | 12.218,3000 | ||||||
| Gezeichnetes Kapital | 3,1000 | 3,1000 | 3,1000 | 3,1000 | 3,1000 | ||||||
| Eigenkapital | 9.669,9000 | 11.735,5000 | 11.276,1000 | 12.392,8000 | 12.199,4000 | ||||||
| Minderheitenanteile | 1 | -,3000 | 4,8000 | 4,7000 | 5,2000 | ||||||
| Passiva, gesamt | 26.684,4000 | 25.964,5000 | 24.126,8000 | 24.638,7000 | 24.417,7000 | ||||||
Gewinn- und Verlustrechnung
| 2016 US GAAP in Mio. USD |
2017 US GAAP in Mio. USD |
2018 US GAAP in Mio. USD |
2019 US GAAP in Mio. USD |
2020 US GAAP in Mio. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Umsatzerlöse | 7.683,9000 | 7.824,1000 | 7.932,9000 | 7.982,2000 | 7.024,5000 | ||||||
| Abschreibungen (Gesamt) | 565,9000 | 603,9000 | 595,9000 | 584,3000 | 597,6000 | ||||||
| Betriebsergebnis | 825,9000 | 808,2000 | 33,8000 | 1.137,5000 | -87,8000 | ||||||
| Zinsergebnis | 2,9000 | 2,2000 | -289,3000 | -226,9000 | -212 | ||||||
| Ergebnis vor Steuern | 399,6000 | 464,6000 | -271,1000 | 905,8000 | -274,4000 | ||||||
| Ertragsteuern | 95 | -1.348,8000 | 108,2000 | -225,7000 | -137 | ||||||
| Gewinnanteil Minderheitsgesellschafter | -1,3000 | -,4000 | -,1000 | -,1000 | 1,5000 | ||||||
| Konzernjahresüberschuss | 305,9000 | 1.813,8000 | -379,2000 | 1.131,6000 | -138,9000 | ||||||
Pro Aktie
Cash Flow
| 2016 US GAAP in Mio. USD |
2017 US GAAP in Mio. USD |
2018 US GAAP in Mio. USD |
2019 US GAAP in Mio. USD |
2020 US GAAP in Mio. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow aus laufender Geschäftstätigkeit | 1.632,2000 | 1.582,3000 | 1.747,4000 | 1.585,8000 | 1.204,5000 | ||||||
| Cash Flow aus Investitionstätigkeit | -1.691,5000 | -510,8000 | -416,6000 | -729,3000 | -613,8000 | ||||||
| Cash Flow aus Finanzierungstätigkeit | -743,2000 | -1.210,5000 | -1.302,2000 | -779,9000 | -421,8000 | ||||||
| Veränderung der liquiden Mittel | -825,2000 | -109,7000 | 18,4000 | 75,1000 | 184,2000 | ||||||
| Anzahl der Mitarbeiter | 18.500 | 18.200 | 19.000 | 19.900 | 20.000 | ||||||
